CRYO-CELL INTL INC (CCEL) Stock Fundamental Analysis
NYSEARCA:CCEL - NYSE Arca - US2288951088 - Common Stock - Currency: USD
Taking everything into account, CCEL scores 4 out of 10 in our fundamental rating. CCEL was compared to 103 industry peers in the Health Care Providers & Services industry. While CCEL is still in line with the averages on profitability rating, there are concerns on its financial health. CCEL is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year CCEL was profitable.
CCEL had a positive operating cash flow in the past year.
Of the past 5 years CCEL 4 years were profitable.
CCEL had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CCEL has a Return On Assets of 0.20%. This is comparable to the rest of the industry: CCEL outperforms 48.54% of its industry peers.
CCEL has a better Return On Invested Capital (7.45%) than 71.84% of its industry peers.
CCEL had an Average Return On Invested Capital over the past 3 years of 7.61%. This is below the industry average of 9.71%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.2% | ||
| ROE | N/A | ||
| ROIC | 7.45% |
ROA(3y)-3.55%
ROA(5y)0.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.61%
ROIC(5y)11.38%
1.3 Margins
CCEL's Profit Margin of 0.40% is in line compared to the rest of the industry. CCEL outperforms 49.51% of its industry peers.
In the last couple of years the Profit Margin of CCEL has declined.
CCEL's Operating Margin of 12.53% is amongst the best of the industry. CCEL outperforms 83.50% of its industry peers.
In the last couple of years the Operating Margin of CCEL has declined.
Looking at the Gross Margin, with a value of 75.79%, CCEL belongs to the top of the industry, outperforming 89.32% of the companies in the same industry.
In the last couple of years the Gross Margin of CCEL has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.53% | ||
| PM (TTM) | 0.4% | ||
| GM | 75.79% |
OM growth 3Y-12.93%
OM growth 5Y-12.62%
PM growth 3Y-44.14%
PM growth 5Y-29.46%
GM growth 3Y2.95%
GM growth 5Y1.88%
2. Health
2.1 Basic Checks
CCEL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CCEL has been reduced compared to 1 year ago.
CCEL has more shares outstanding than it did 5 years ago.
CCEL has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.09, we must say that CCEL is in the distress zone and has some risk of bankruptcy.
CCEL has a Altman-Z score of 0.09. This is in the lower half of the industry: CCEL underperforms 77.67% of its industry peers.
The Debt to FCF ratio of CCEL is 1.59, which is an excellent value as it means it would take CCEL, only 1.59 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CCEL (1.59) is better than 84.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 1.59 | ||
| Altman-Z | 0.09 |
ROIC/WACC0.7
WACC10.6%
2.3 Liquidity
CCEL has a Current Ratio of 0.58. This is a bad value and indicates that CCEL is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.58, CCEL is not doing good in the industry: 88.35% of the companies in the same industry are doing better.
CCEL has a Quick Ratio of 0.58. This is a bad value and indicates that CCEL is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CCEL (0.54) is worse than 85.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.58 | ||
| Quick Ratio | 0.54 |
3. Growth
3.1 Past
CCEL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 101.72%, which is quite impressive.
The earnings per share for CCEL have been decreasing by -29.04% on average. This is quite bad
CCEL shows a small growth in Revenue. In the last year, the Revenue has grown by 2.33%.
CCEL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.11% yearly.
EPS 1Y (TTM)101.72%
EPS 3Y-41.85%
EPS 5Y-29.04%
EPS Q2Q%-57.14%
Revenue 1Y (TTM)2.33%
Revenue growth 3Y3.46%
Revenue growth 5Y0.11%
Sales Q2Q%1.49%
3.2 Future
CCEL is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -68.82% yearly.
CCEL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.77% yearly.
EPS Next Y-304%
EPS Next 2Y-68.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.59%
Revenue Next 2Y0.77%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 252.50, the valuation of CCEL can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of CCEL indicates a slightly more expensive valuation: CCEL is more expensive than 60.19% of the companies listed in the same industry.
CCEL is valuated expensively when we compare the Price/Earnings ratio to 27.45, which is the current average of the S&P500 Index.
CCEL is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 252.5 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CCEL is valued a bit cheaper than 72.82% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CCEL indicates a rather cheap valuation: CCEL is cheaper than 90.29% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.68 | ||
| EV/EBITDA | 8.72 |
4.3 Compensation for Growth
CCEL's earnings are expected to decrease with -68.82% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-68.82%
EPS Next 3YN/A
5. Dividend
5.1 Amount
CCEL has a Yearly Dividend Yield of 15.97%, which is a nice return.
In the last 3 months the price of CCEL has falen by -21.71%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 2.37, CCEL pays a better dividend. On top of this CCEL pays more dividend than 100.00% of the companies listed in the same industry.
CCEL's Dividend Yield is rather good when compared to the S&P500 average which is at 2.42.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 15.97% |
5.2 History
CCEL has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
3137.42% of the earnings are spent on dividend by CCEL. This is not a sustainable payout ratio.
DP3137.42%
EPS Next 2Y-68.82%
EPS Next 3YN/A
NYSEARCA:CCEL (7/3/2025, 7:08:01 PM)
5.05
-0.05 (-0.96%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners7.68%
Inst Owner Change-0.09%
Ins Owners40.17%
Ins Owner Change0%
Market Cap40.80M
Analysts82.86
Price Target8.67 (71.68%)
Short Float %0.17%
Short Ratio0.6
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 15.97% |
Yearly Dividend0.25
Dividend Growth(5Y)N/A
DP3137.42%
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.21%
Min Revenue beat(2)-1.52%
Max Revenue beat(2)-0.9%
Revenue beat(4)0
Avg Revenue beat(4)-1.19%
Min Revenue beat(4)-1.52%
Max Revenue beat(4)-0.9%
Revenue beat(8)0
Avg Revenue beat(8)-1.59%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-350%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 252.5 | ||
| Fwd PE | N/A | ||
| P/S | 1.27 | ||
| P/FCF | 7.68 | ||
| P/OCF | 5.57 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.72 |
EPS(TTM)0.02
EY0.4%
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)0.66
FCFY13.02%
OCF(TTM)0.91
OCFY17.94%
SpS3.97
BVpS-1.81
TBVpS-2.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.2% | ||
| ROE | N/A | ||
| ROCE | 9.43% | ||
| ROIC | 7.45% | ||
| ROICexc | 8.11% | ||
| ROICexgc | 8.75% | ||
| OM | 12.53% | ||
| PM (TTM) | 0.4% | ||
| GM | 75.79% | ||
| FCFM | 16.55% |
ROA(3y)-3.55%
ROA(5y)0.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)7.61%
ROIC(5y)11.38%
ROICexc(3y)7.98%
ROICexc(5y)14.72%
ROICexgc(3y)8.63%
ROICexgc(5y)16.85%
ROCE(3y)9.64%
ROCE(5y)14.41%
ROICexcg growth 3Y-17.95%
ROICexcg growth 5Y-25.17%
ROICexc growth 3Y-16.74%
ROICexc growth 5Y-23.68%
OM growth 3Y-12.93%
OM growth 5Y-12.62%
PM growth 3Y-44.14%
PM growth 5Y-29.46%
GM growth 3Y2.95%
GM growth 5Y1.88%
F-Score8
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 1.59 | ||
| Debt/EBITDA | 1.7 | ||
| Cap/Depr | 234.65% | ||
| Cap/Sales | 6.26% | ||
| Interest Coverage | 1.99 | ||
| Cash Conversion | 150.07% | ||
| Profit Quality | 4125.62% | ||
| Current Ratio | 0.58 | ||
| Quick Ratio | 0.54 | ||
| Altman-Z | 0.09 |
F-Score8
WACC10.6%
ROIC/WACC0.7
Cap/Depr(3y)548.95%
Cap/Depr(5y)370.25%
Cap/Sales(3y)23.15%
Cap/Sales(5y)15.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)101.72%
EPS 3Y-41.85%
EPS 5Y-29.04%
EPS Q2Q%-57.14%
EPS Next Y-304%
EPS Next 2Y-68.82%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.33%
Revenue growth 3Y3.46%
Revenue growth 5Y0.11%
Sales Q2Q%1.49%
Revenue Next Year0.59%
Revenue Next 2Y0.77%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9.34%
EBIT growth 3Y-9.92%
EBIT growth 5Y-12.52%
EBIT Next Year-1.89%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y266.76%
FCF growth 3Y-15.98%
FCF growth 5Y-8.62%
OCF growth 1Y-15.93%
OCF growth 3Y-8.81%
OCF growth 5Y-1.01%